Cambridge Trust’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $44.6M | Buy |
338,060
+102,342
| +43% | +$12.6M | 1.69% | 16 |
|
|
2023
Q4 | $25.7M | Sell |
235,718
-267
| -0.1% | -$27.7K | 1.07% | 31 |
|
|
2023
Q3 | $24.3M | Buy |
235,985
+3,516
| +2% | +$379K | 1.12% | 29 |
|
|
2023
Q2 | $26.8M | Sell |
232,469
-3,613
| -2% | -$410K | 1.21% | 27 |
|
|
2023
Q1 | $25.1M | Sell |
236,082
-18,520
| -7% | -$2M | 1.2% | 28 |
|
|
2022
Q4 | $28.2M | Sell |
254,602
-4,242
| -2% | -$434K | 1.26% | 29 |
|
|
2022
Q3 | $22.3M | Buy |
258,844
+12,945
| +5% | +$1.16M | 1.06% | 31 |
|
|
2022
Q2 | $22.4M | Buy |
245,899
+19,827
| +9% | +$1.76M | 0.98% | 35 |
|
|
2022
Q1 | $18.5M | Buy |
226,072
+8,724
| +4% | +$688K | 0.65% | 53 |
|
|
2021
Q4 | $16.7M | Buy |
217,348
+19,811
| +10% | +$1.58M | 0.54% | 63 |
|
|
2021
Q3 | $14.8M | Sell |
197,537
-3,902
| -2% | -$297K | 0.56% | 64 |
|
|
2021
Q2 | $15.7M | Sell |
201,439
-20,369
| -9% | -$1.52M | 0.59% | 62 |
|
|
2021
Q1 | $16.3M | Sell |
221,808
-314,252
| -59% | -$23.2M | 0.67% | 57 |
|
|
2020
Q4 | $41.8M | Buy |
536,060
+15,358
| +3% | +$1.17M | 1.98% | 11 |
|
|
2020
Q3 | $41.2M | Buy |
520,702
+268
| +0.1% | +$21K | 2.13% | 9 |
|
|
2020
Q2 | $40.6M | Buy |
520,434
+1,558
| +0.3% | +$117K | 2.13% | 9 |
|
|
2020
Q1 | $38.1M | Buy |
518,876
+6,495
| +1% | +$510K | 2.62% | 6 |
|
|
2019
Q4 | $44.5M | Buy |
512,381
+1,288
| +0.3% | +$106K | 2.35% | 6 |
|
|
2019
Q3 | $41.1M | Sell |
511,093
-3,387
| -0.7% | -$271K | 2.38% | 7 |
|
|
2019
Q2 | $41.2M | Sell |
514,480
-2,497
| -0.5% | -$191K | 2.39% | 7 |
|
|
2019
Q1 | $41M | Sell |
516,977
-18,675
| -3% | -$1.4M | 2.45% | 6 |
|
|
2018
Q4 | $39.1M | Sell |
535,652
-3,911
| -0.7% | -$276K | 2.69% | 3 |
|
|
2018
Q3 | $36.5M | Buy |
539,563
+1,298
| +0.2% | +$82.7K | 2.11% | 12 |
|
|
2018
Q2 | $31.2M | Sell |
538,265
-6,828
| -1% | -$385K | 1.94% | 13 |
|
|
2018
Q1 | $28.3M | Sell |
545,093
-9,683
| -2% | -$523K | 1.81% | 14 |
|
|
2017
Q4 | $29.8M | Sell |
554,776
-30,033
| -5% | -$1.66M | 1.88% | 12 |
|
|
2017
Q3 | $35.7M | Buy |
584,809
+424
| +0.1% | +$25.7K | 2.4% | 7 |
|
|
2017
Q2 | $35.7M | Sell |
584,385
-18,279
| -3% | -$1.11M | 2.47% | 6 |
|
|
2017
Q1 | $36.5M | Buy |
602,664
+1,070
| +0.2% | +$64.9K | 2.42% | 6 |
|
|
2016
Q4 | $33.8M | Buy |
601,594
+107,412
| +22% | +$6.29M | 2.38% | 7 |
|
|
2016
Q3 | $29.4M | Buy |
494,182
+7,719
| +2% | +$451K | 2.15% | 10 |
|
|
2016
Q2 | $26.7M | Buy |
486,463
+2,421
| +0.5% | +$129K | 2.05% | 8 |
|
|
2016
Q1 | $24.4M | Buy |
484,042
+5,993
| +1% | +$294K | 2.01% | 12 |
|
|
2015
Q4 | $24.1M | Buy |
478,049
+4,605
| +1% | +$232K | 1.97% | 12 |
|
|
2015
Q3 | $22.3M | Sell |
473,444
-1,686
| -0.4% | -$89.6K | 1.96% | 12 |
|
|
2015
Q2 | $25.8M | Sell |
475,130
-3,676
| -0.8% | -$206K | 2.14% | 8 |
|
|
2015
Q1 | $26.3M | Buy |
478,806
+1,699
| +0.4% | +$96.2K | 2.21% | 6 |
|
|
2014
Q4 | $25.9M | Buy |
477,107
+11,485
| +2% | +$640K | 2.24% | 9 |
|
|
2014
Q3 | $26.3M | Buy |
465,622
+427
| +0.1% | +$24K | 2.34% | 9 |
|
|
2014
Q2 | $25.7M | Sell |
465,195
-19,413
| -4% | -$1.06M | 2.22% | 9 |
|
|
2014
Q1 | $26.3M | Sell |
484,608
-1,718
| -0.4% | -$89K | 2.42% | 8 |
|
|
2013
Q4 | $23.2M | Sell |
486,326
-77,788
| -14% | -$3.56M | 2.16% | 9 |
|
|
2013
Q3 | $25.6M | Sell |
564,114
-4,733
| -0.8% | -$216K | 2.55% | 8 |
|
|
2013
Q2 | $25.2M | Buy |
+568,847
| New | +$25.4M | 2.61% | 8 |
|
Other funds holding MRK
Cambridge Trust's MRK Position: Q1 2024 in Review
Cambridge Trust increased its Merck (MRK) stake by 43% in Q1 2024, buying an estimated $12.6M and bringing the position to 338,060 shares worth $44.6M. The position accounts for 1.69% of the portfolio, ranked #16.
Cambridge Trust first reported a position in MRK in Q2 2013 and has held it in 44 quarters since. 3,536 funds tracked by Wall St. Rank hold MRK as of Q1 2024.
- Cambridge Trust held 338,060 shares of Merck worth $44.6M as of Q1 2024.
- Cambridge Trust bought 102,342 Merck shares in Q1 2024, an estimated $12.6M.
- Merck made up 1.69% of Cambridge Trust's portfolio in Q1 2024, its #16 holding.
- Cambridge Trust first reported a position in Merck in Q2 2013 and has held it in 44 quarters since.
- 3,536 funds tracked by Wall St. Rank held Merck as of Q1 2024.
Based on Cambridge Trust's 13F filing for Q1 2024, filed 30 May 2024.